Trial
NCT02865915
MLE4901 vs. Placebo for the Treatment of PCOS
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Millendo Therapeutics US, Inc.
Collaborators
Medpace, Inc.; Covance
Condition
Polycystic Ovary Syndrome (PCOS)
Intervention
MLE4901
Why stopped
The risk/benefit profile no longer indicated continued development.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-01